Angela Welle

PHD Doctor of Philosophy,  The Johns Hopkins Hospital 

Location: Africa

Consulting Services

Grant Submission Career Advice and Mentoring Data Science-Bioinformatics IT-Web-Mobile Technology Journal Manuscript

Areas Of Interest

Q N ethylmaleimide Sensitive Factor Attachment Protein Receptors Clozaril Human Genomes Fat Cells Plans, Physician Incentive Roniviridae Infection, Clostridium difficile Pneumonia, Bronchial Receptors, TNF-Related Apoptosis-Inducing Ligand Type I Collagen Procedures, Urological Surgical Digestion Paraneoplastic Anti-NMDAR Encephalitides C1 Esterase Inhibitor, Deficiency Of Infection, Brucella Walk Test, 6-Minute Cerebellar Contusions Sch-29851 Complete Mastoidectomies Future Generation Opportunistic Infections Protein Glycosylation Revanil Blood Culture Organism Water Status Cogentinol Bronchitides Selenium Trioxide Paleocortices Pigeons, Domestic Influenza D Virus

Professional Narrative

Dr. Angela Welle was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Welle has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Director Medicine, Amgen 1998
Director Medicine, Mayo Clinic 1999

Education

Doctor of osteopathic medicine, Harvard Medical School 1997
Doctor of medicine, Weill Medical College 2002

Referees


Publications

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :